Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein

Journal of Biotechnology

Volumn 92, Issue 2, 2001, Pages 159-168

  Wuest T ^a   Moosmayer, D ^a   Pfizenmaier, K ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Bispecific antibody; Cytotoxic T cells; Fibroblast activation protein

Indexed keywords

BIOMARKERS; CELLS; PROTEINS; TUMORS;

BISPECIFIC REAGENTS;

ANTIBODIES;

BISPECIFIC ANTIBODY; CD3 ANTIGEN; FIBROBLAST ACTIVATION PROTEIN; IMMUNOMODULATING AGENT; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EUKARYOTIC CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; IN VITRO STUDY; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; STROMA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGENS, CD3; ANTIGENS, NEOPLASM; BASE SEQUENCE; BIOTECHNOLOGY; CELL LINE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DNA, RECOMBINANT; GENETIC VECTORS; GROWTH SUBSTANCES; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; NEOPLASMS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EUKARYOTA;

EID: 0035909785     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(01)00355-8     Document Type: Conference Paper

References (28)

1. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
2. Inhibitory Fc receptors modulate in vivo cytoxicity against tumour targets
3. Induction of angiogenesis during the transition from hyperplasia to neoplasia
4. Immunohistochemical analysis of human neuronectin expression in normal, reactive, and neoplastic tissues
5. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers
6. Tumour-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: The role of targeted T-cell co-stimulation via CD28
7. Molecular cloning and expression of human and rat tumour necrosis factor receptor chain (p60) and its soluble derivative, tumour necrosis factor-binding protein
8. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody
9. Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation
10. Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies
11. Specific targeting of cytokine-secreting cells: A bispecific diabody recognizing human interleukin-6 and CD3 induces T cell-mediated killing
12. The use of hybrid hybridomas to target human cytotoxic T lymphocytes
13. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumour cell cytotoxicity
14. Biological properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3
15. Hybrid hybridomas and their use in immunohistochemistry
16. Fibroblast activation protein, a dual specificity serine protease expressed in human tumour stromal fibroblasts
17. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumour activity
18. Cure of xenografted human tumours by bispecific monoclonal antibodies and human T cells
19. Cell-surface glycoproteins of human sarcomas: Differential expression in normal and malignant tissues and cultured cells
20. Regulation and hereromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin
21. Molecular cloning of fibroblast activation protein alpha, a member of the protease family selectively expressed in stromal fibroblasts of epithelial cancers
22. Cytotoxic and antitumoral activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells
23. Antibody-targeted superantigens in cancer immunotherapy
24. Human T-cells targeted with anti-T3 cross-linked to antitumour antibody prevent tumour growth in nude mice
25. Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on Hläv infected cells
26. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma
27. Antibody targeting in metastatic colon cancer: A phase I study of monoclonal F19 against a cell-surface protein of reactive tumour stromal fibroblasts
28. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy